Clinical Trial Update: A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase II single-arm trial evaluating cadonilimab in combination with chemoradiotherapy for oligometastatic stage IVB cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Xiangbo Wan | Conditions: Cervical Cancer Stage IV | Phase 2 | Status: RECRUITING